How does Talimogene Laherparepvec work?
Robert Guerrero How does Talimogene Laherparepvec work?
When talimogene laherparepvec is injected into the tumor it causes a breakdown of tumor cells followed by a release of tumor-derived antigens which together with the virally derived GM-CSF may promote an immune response against the tumor.
How do oncolytic viruses work?
Oncolytic viruses are a form of immunotherapy that uses viruses to infect and destroy cancer cells. Viruses are particles that infect or enter our cells and then use the cell’s genetic machinery to make copies of themselves and subsequently spread to surrounding uninfected cells.
Is T-VEC a gene therapy?
T-VEC is an oncolytic virus therapy, a treatment that uses a virus to infect and kill cancer cells while avoiding normal, healthy cells. T-VEC is made from a genetically modified herpes virus, commonly known as the cold sore virus. The therapy is designed to replicate inside melanoma cells to kill those cells.
What type of medications may diminish the therapeutic effect of Talimogene Laherparepvec IMLYGIC and should therefore be avoided by patients taking the drug?
IMLYGIC is sensitive to acyclovir. Acyclovir or other antiviral agents may interfere with the effectiveness of IMLYGIC. Therefore, consider the risks and benefits of IMLYGIC treatment before administering antiviral agents to manage herpetic infection.
How is TCC administered?
T-VEC is injected directly into the melanoma lesions. The second treatment must be administered three weeks after the initial injection. Patients receive subsequent doses every two-three weeks for six months or, for as long as you have tumors.
What kills melanoma cells?
When melanoma cells are heated by laser beams, tiny bubbles form around the pigment proteins inside the cells. As these bubbles rapidly expand, they can physically destroy the cells. Although laser beams can also heat pigment in red blood cells, bubbles do not form and so there is no danger of harming healthy cells.
What are the benefits of oncolytic virus therapy?
Oncolytic virus therapy aims to eradicate tumours using viruses which only infect and destroy targeted tumour cells. It is urgent to improve understanding and outcomes of this promising cancer treatment because oncolytic virus therapy could provide sensible solutions for many patients with cancer.
What makes a virus oncolytic?
A type of virus that infects and lyses (breaks down) cancer cells but not normal cells. Oncolytic viruses can occur naturally or can be made in the laboratory by changing other viruses. Certain oncolytic viruses are being studied in the treatment of cancer.
Is T-VEC FDA approved?
On October 27, the U.S. Food and Drug Administration (FDA) approved the first oncolytic virus therapy, talimogene laherparepvec (T-VEC, or Imlygic®). The agency approved T-VEC for the treatment of some patients with metastatic melanoma that cannot be surgically removed.
Is IMLYGIC a gene therapy?
Imlygic is a modified genetic therapy inserted directly into tumors with a viral vector, where the gene replicates and produces a protein that stimulates an immune response to kill cancer cells.
What foods fight melanoma?
Antioxidants and Melanoma Studies have found that higher intake of retinol-rich foods, such as fish, milk, eggs, dark green leafy vegetables, and orange/yellow fruits and vegetables led to a 20 percent reduced risk of developing melanoma.
